Vaccines – Page 8

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

7 months ago talkbio0Tagged Administration occupational activities, AstraZeneca, Drug Industry, Economic Growth, Government, Investments, Labor (Childbirth), Manufacturing, UK, Vaccines

AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry

Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings

7 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Chronic disease, Confirmation, Hearings, public health policy, Robert F. Kennedy, Secretary Nomination, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., HHS Secretary nomination, Senate confirmation hearings, vaccine skepticism, chronic disease focus, public health policy, Trump administration

Senate Hearing for RFK Jr. Amid Strong Public Support for Vaccine Access

7 months ago talkbio0Tagged Department of Health and, FDA-approved, Hearing, Homo sapiens, public entity, RFK Jr., Senate, Services, United States Food and Drug Administration, Vaccines

RFK Jr., Senate hearing, vaccine access, public support, FDA-approved vaccines, Department of Health and Human Services nomination

RFK Jr. Faces Intense Scrutiny in Senate Confirmation Hearings for HHS Secretary

7 months ago talkbio0Tagged Confirmation, doubt, Health, Hearings, Human Services Secretary, Republican, Robert F. Kennedy, Senate, stance, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., Senate confirmation hearings, Health and Human Services Secretary, Trump nominee, vaccine stance, Republican doubts

RFK Jr.’s Financial Ties to Gardasil Litigation Spark Conflict-of-Interest Concerns

7 months ago talkbio0Tagged CHARGE Syndrome, Conflict (Psychology), Gardasil, Litigation, Merck, RFK Jr., Secretary Nomination, Vaccines

RFK Jr., Gardasil, Merck, Conflict of Interest, Vaccine Litigation, HHS Secretary Nomination

HHS Awards Moderna $590 Million to Expedite Bird Flu Vaccine Development

7 months ago talkbio0Tagged Aves, CHARGE Syndrome, Moderna, mRNA Vaccine, pandemic preparedness, Vaccines

Moderna, HHS, Bird Flu Vaccine, Avian Influenza, mRNA Vaccine, Pandemic Preparedness

Pharmaceutical CEOs Emphasize Transparency to Counter Anti-Vaccine Sentiment in the US

7 months ago talkbio0Tagged anti-vaccine, public health medicine (field), sanofi, SmithKline Beecham, Translucent, Urinary hesitation, Vaccines

Anti-vaccine movement, Transparency, GSK, Sanofi, Vaccine hesitancy, Public health

Moderna Slashes 2025 Revenue Forecast, Expands Cost-Cutting Measures Amid Vaccine Sales Decline

7 months ago talkbio0Tagged 2025, competition, cost-cutting measures, COVID19 (disease), decline, Market, Moderna, Vaccination, Vaccines

Moderna, 2025 revenue forecast, cost-cutting measures, vaccine sales decline, COVID-19 vaccine market competition, falling vaccination rates.

FDA Mandates Guillain-Barré Syndrome Warning for Pfizer and GSK RSV Vaccines

8 months ago talkbio0Tagged Abrysvo, Arexvy, Cautionary Warning, Guillain-Barré syndrome, Pfizer, Respiratory syncytial virus, SmithKline Beecham, United States Food and Drug Administration, Vaccines

RSV vaccines, Guillain-Barré syndrome, FDA warning, Pfizer, GSK, Abrysvo, Arexvy

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

8 months ago talkbio0Tagged asset, Biological Factors, BIOSECURE, Dundalk, Facility (object), Ireland, Merck, regulatory, Sales - occupational activity, strategic shift, Vaccines, WuXi

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act